期刊文献+

医疗机构相关性感染性心内膜炎的流行病学特点及其预后 被引量:7

Epidemiology and prognosis of healthcare-associated infective endocarditis
原文传递
导出
摘要 目的描述医疗机构相关性感染性心内膜炎(HAIE)的特点,并分析引起感染性心内膜炎(IE)死亡的危险因素。方法连续收集1992年至2012年复旦大学附属华山医院确诊的IE患者,分为HAIE和社区获得性IE(CAIE),比较HAIE和CAIE的流行病学及临床特点。采用Logistic回归筛选引起IE患者住院死亡的危险因素。结果共纳入154例IE患者,其中126例为CAIE,占81.8%,28例为HAIE,占18.2%。HAIE与CAIE患者比较,发病前基础情况较差(Charlson合并症评分≥2分患者比例为35.7%比15.1%;χ^2=6.382,P=0.012),更多人造瓣膜置换史(35.7%比7.1%;χ^2=17.291,P〈0.01),风湿性心脏病史(35.7%比10.3%;χ^2=11.631,P=0.002),免疫抑制剂或糖皮质激素治疗史(21.4%比4.0%;χ^2=10.530,P=0.005)和并发急性心力衰竭(17.9%比4.8%;χ^2=5.923,P=0.029)。CAIE以草绿色链球菌感染为主(χ^2=5.489,P=0.019),而HAIE以葡萄球菌、肠球菌感染为主(50.1%),其他病原体感染也多见于HAIE(χ^2=5.870,P=0.026)。住院期间共死亡10例,住院病死率为6.5%。HAIE的病死率显著高于CAIE(17.9%比4.0%;χ^2=7.278,P=0.018)。多因素回归分析表明,未手术治疗(OR=0.081,95%CI:0.008~0.873,P=0.038)、低白蛋白水平(OR=0.754,95%CI:0.587~0.967,P=0.026)、脑卒中(OR=33.777,95%CI:2.751~414.743,P=0.006)和HAIE(OR=11.952,95%CI:1.045~136.709,P=0.046)是引起IE患者死亡的独立危险因素。结论HAIE常见且流行病学特点有别于CAIE,可增加患者的病死率。 Objective To describe the characteristics of healthcare-associated infective endocarditis (HALE) and to investigate the risk factors of infective endocarditis (IE) case fatality. Methods All consecutive cases of definite IE diagnosed from 1992 to 2012 were collected and categorized into HAIE and community acquired IE (CAIE). The epidemiological and clinical features of HAIE and CAIE were compared. Risk factors for in-hospital case fatality were analyzed by Logistic regression. Results One hundred and fifty-four patients with IE were enrolled; 126 (81.8%) were CAIE and 28 (18.2%) were HAIE. Compared with CAIE patients, HAIE patients were in poorer condition (Charlson comorbidity scale≥2: 35. 7% vs 15. 1% ;χ^2= 6. 382, P= 0. 012), more frequently associated with a history of prosthetic valve replacement (35.7% vs 7.1% χ^2= 17. 291, P〈0.01), more rheumatic heart disease (35.7 % vs 10.3 % ; χ^2= 11.631, P = 0. 002), more recieved immunosuppressive or glucocorticoid therapy (21.4% vs 4.0% ;χ^2=10. 530, P=0. 005) and more acute heart failure (17.9% vs 4.8% ;χ^2==5. 923, P=0. 029). Viridans group streptococci infection predominated in CAIE (χ^2=5. 489, P=0. 019), while staphylococci and enterococci infections (50. 1%) were frequent in HAIE. Other bacterial pathogen infections were more common in HAlE (%2 =5. 870, P=0. 026). Ten patients died before discharge and the case fatality rate in-hospital was 6.5% (10/154). Case fatality rate in HAIE (17.9%) was significantly higher than CAIE (4. 0%;χ^2=7. 278, P= 0. 018). Surgery treatment, albumin level, stroke and HAIE were independent risk factors for IE-related deaths. Odds ratios (OR) were 0. 081 (95% CI:0.008-0.873), 0. 754 (95%CI: 0.587-0. 967), 33. 777 (95MCI:2. 751-414. 743) and 11. 952 (95%CI:1. 045-136. 709), respectively. Conclusion HAIE is common and distinctive from CAIE in epidemiology and prognosis,which increases patient fatality.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2015年第3期132-136,共5页 Chinese Journal of Infectious Diseases
关键词 心内膜炎 细菌性 社区获得性感染 医疗机构相关性感染性心内膜炎 流行病学 危险因素 Endocarditis, bacterial Community-acquired infections Healthcare-associated infective endocarditis Epidemiology Risk factors
  • 相关文献

参考文献17

  • 1Que YA, Moreillon P. Infective endocarditis I-J3. Nat Rev Cardiol, 2011,8(6) :322-336.
  • 2姚冬婷,应春妹,张纪伟,汪雅萍,杨海慧,张灏旻.感染性心内膜炎患者致病菌及其耐药性变迁[J].上海交通大学学报(医学版),2013,33(8):1108-1111. 被引量:17
  • 3Benito N, Mir6 associated native JM, de Lazzari E, valve endocarditis et al. Health care- importance of non- nosocomial acquisition [J]. Ann Intern Med, 2009,150 (9) : 586-594.
  • 4Fern6ndez-Hidalgo N, Almirante B, Tornos P, et al. Contemporary epidemiology and prognosis of health care- associated infective endocarditis [J]. Clin Infect Dis, 2008,47(10):1287-1297.
  • 5Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies.. development and validation [-J~. J Chronic Dis, 1987,40 (5) : 373-383.
  • 6Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases ( ESCMID ) and the International Society of Chemotherapy (ISC) for Infection and Cancer [J]. Eur Heart J, 2009,30(19) ~2369-2413.
  • 7Friedman ND, Kaye KS, Stout JE, et al. Health care-- associated bloodstream infections in adults: a reason to change the accepted de~inition of community-acquired infections [-J~. Ann Intern Med, 2002,137(10):791-797.
  • 8Giannitsioti E, Skiadas I, Antoniadou A, et al. Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk EJ~. Clin Microbiol Infect, 2007,13(8) : 763-769.
  • 9Hill EE, Herijgers P, Claus P, et al. Infective endocarditis: changing epidemiology and predictors ot[ 6-month mortality: a prospective cohort study [J]. Eur Heart J, 2007,28 (2) : 196- 203.
  • 10Wu KS, Lee SS, Tsai HC, et al. Non-nosoeomial healthcare- associated infective endocarditis in Taiwan, an underrecognized disease with poor outcome [J/OL]. BMC Infect Dis, 2011,11:221[-2011-08-17~. http://www, biomedcentraL com/1471- 2334/11/221.

二级参考文献6

  • 1Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement[S]. PA:CLSI, 2012: M100-S22.
  • 2Kiefer TL, Bashore TM. Infective endocarditis: a comprehensive overview[J]. Rev Cardiovasc Med, 2012, 13 (2 -3): e105 - e120.
  • 3Hoen B, Duval X. Epidemiology of infective endocarditis[J]. Rev Prat, 2012, 62(4) : 511 -514.
  • 4Yew HS, Murdoch DR. Global trends in infective endocarditis epidemiology[ J]. Curr Infect Dis Rep, 2012, 14(4) : 367 - 372.
  • 5Habib G, Hoen B, Tornns P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treat- ment of Infective Endocarditis of the European Society of Cardiology ( ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer[ J]. Eur Heart J, 2009, 30(19) : 2369 -2413.
  • 6Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheu- matic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America[J]. Circulation, 2005, 111 (23): e394 - e343.

共引文献16

同被引文献34

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部